Richard S. Kaplan
University of Illinois Urbana-Champaign
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Ovarian cancer diagnosis and treatment
Solid evidence · 1 supporting paper · latest 2026
Retirement, Disability, and Employment
Solid evidence · 1 supporting paper · latest 2026
Insurance, Mortality, Demography, Risk Management
Solid evidence · 1 supporting paper · latest 2026
HER2/EGFR in Cancer Research
Solid evidence · 1 supporting paper · latest 2026
demographic modeling and climate adaptation
Supporting evidence · 1 supporting paper · latest 2026
PARP inhibition in cancer therapy
Supporting evidence · 1 supporting paper · latest 2026
Publications (2)
ICON8B: GCIG phase III randomised trial comparing first-line weekly dose-dense chemotherapy + bevacizumab to three-weekly chemotherapy + bevacizumab in high-risk stage III-IV epithelial ovarian cancer: final overall survival (OS) analysis
2026DOI
Gender Discrimination and Retirement Plan Distributions
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- University of Illinois Urbana-Champaign
Source: OpenAlex · retrieved 2026-09-29